Loss of SFXN1 mitigates lipotoxicity and predicts poor outcome in non-viral hepatocellular carcinoma

Hepatocellular carcinoma (HCC) imposes a huge global burden, arising from various etiological factors such as hepatitis virus infection and metabolic syndrome. While prophylactic vaccination and antiviral treatment have decreased the incidence of viral HCC, the growing prevalence of metabolic syndro...

Descripción completa

Detalles Bibliográficos
Autores principales: Yagi, Kohei, Shimada, Shu, Akiyama, Yoshimitsu, Hatano, Megumi, Asano, Daisuke, Ishikawa, Yoshiya, Ueda, Hiroki, Watanabe, Shuichi, Akahoshi, Keiichi, Ono, Hiroaki, Tanabe, Minoru, Tanaka, Shinji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256799/
https://www.ncbi.nlm.nih.gov/pubmed/37296228
http://dx.doi.org/10.1038/s41598-023-36660-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256799/
https://www.ncbi.nlm.nih.gov/pubmed/37296228
http://dx.doi.org/10.1038/s41598-023-36660-w

Ejemplares similares